See analyst estimates and all valuation multiples for Pharmacies
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $150B | 0.4x | 9.8x | |
| $38.7B | 0.3x | 10.3x | |
| $26.1B | 8.0x | 32.4x | |
| $9.3B | 1.1x | 22.3x | |
| $8.2B | 1.9x | 36.0x | |
| $7.5B | 0.2x | 3.5x | |
| $7.4B | 1.0x | 10.3x | |
| $6.8B | 0.6x | 11.7x | |
| $5.7B | 0.8x | 9.6x | |
| $5.2B | 2.0x | 15.1x | |
| $4.8B | 0.7x | 11.2x | |
| $4.4B | 1.7x | 10.1x | |
| $4.0B | 0.4x | 9.4x | |
| $3.9B | 1.1x | 9.8x | |
| $3.9B | 0.6x | 9.1x | |
| $3.7B | 0.2x | 5.7x | |
| $3.6B | 0.6x | 8.7x | |
| $3.4B | 0.6x | 7.9x | |
| $2.8B | 0.7x | 6.2x | |
| $2.7B | 0.9x | 52.8x | |
| $2.7B | 0.8x | 10.5x | |
| $2.7B | 0.4x | 5.4x | |
| $2.4B | 0.8x | 7.3x | |
| $2.3B | 1.3x | 9.2x | |
| $1.9B | 0.9x | 10.6x | |
| $1.6B | 2.0x | 6.1x | |
| $1.4B | 2.0x | 24.3x | |
| $1.4B | 1.3x | 11.0x | |
| $1.4B | 0.4x | 6.2x | |
| $1.3B | 0.5x | 10.7x | |
| $1.2B | n/a | n/a | |
| $1.1B | n/a | n/a | |
| $1.0B | n/a | n/a | |
| $1.0B | n/a | n/a | |
| $964M | 0.4x | 6.6x | |
| $908M | 0.7x | n/a | |
| $839M | 1.4x | 15.5x | |
| $748M | 0.6x | -15.3x | |
| $688M | n/a | n/a | |
| $665M | n/a | n/a | |
| $646M | n/a | n/a | |
| $607M | 0.2x | 26.0x | |
| $278M | 0.1x | n/a | |
| $264M | n/a | n/a | |
| $203M | 0.5x | 8.5x | |
| $147M | 0.1x | 4.3x | |
| $144M | n/a | n/a | |
| $105M | n/a | n/a | |
| $83.9M | 0.6x | 15.4x | |
| $48.5M | n/a | n/a | |
| $27.9M | 0.4x | 44.2x | |
| $26.4M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharmacies